Pharmaceutical Medicine

, Volume 23, Issue 5–6, pp 289–297 | Cite as

Strategies to Measure and Improve Patient Adherence in Clinical Trials

Review Article

Abstract

Investigators conducting clinical trials need to appreciate the important role of adherence in clinical research. Poor compliance may reduce the power of a study and lead to an underestimation of the efficacy of a treatment and dismissal of a potentially useful therapeutic agent. In general, medication adherence of participants in clinical trials is better than in clinical practice. The study protocol should indicate how adherence will be handled, both in terms of measurement and in the data analysis. Unfortunately, no perfect method for assessing compliance exists, complicating research in this area. Techniques commonly employed in research include self-reporting (such as diaries), pill counts and electronic monitors with a combination of methods preferred. Selection of which method(s) to use will depend on the goals of the study, the type of noncompliance of interest and the resources available. When designing a clinical trial, interventions to facilitate optimal adherence should be considered. One strategy to attempt to minimize the number of study subjects who will be poor adherers is to attempt to identify these individuals and eliminate them using a runin period. Study participants should be well informed and expectations with respect to study procedures should be realistic. Factors that affect compliance should be taken into account in drug development in an effort to improve medication-taking behaviour. Drugs with less frequent dosing to enhance patient convenience or fixed-dose combination drugs to reduce the pill burden are possible options, as is the use of specialized containers and packaging. Newer technologies such as ‘smart’ pill boxes and text messaging offer promise; however, further research into their usefulness and patient acceptance needs to be undertaken. This article will provide an overview of patient adherence with drugs in the clinical trial setting including factors that affect patient adherence, methods to monitor adherence and strategies to minimize the barriers to adherence, including the use of newer technologies.

References

  1. 1.
    Bonaccorso S, Sturchio JL. Perspectives from the pharmaceutical industry. BMJ 2003; 327: 863–4PubMedCrossRefGoogle Scholar
  2. 2.
    World Health Organization. Adherence to long-term therapies: evidence for action [online]. Available from URL: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf [Accessed 2009 Sep 20]
  3. 3.
    Tilson HH. Adherence or compliance: changes in terminology. Ann Pharmacother 2004; 38: 161–2PubMedCrossRefGoogle Scholar
  4. 4.
    Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44–7PubMedCrossRefGoogle Scholar
  5. 5.
    Pullar T. Compliance with drug therapy. Br J Clin Pharmacol 1991; 32: 535–9PubMedCrossRefGoogle Scholar
  6. 6.
    Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377–8PubMedCrossRefGoogle Scholar
  7. 7.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487–97PubMedCrossRefGoogle Scholar
  8. 8.
    Ellis S, Shumaker S, Sieber W, et al. Adherence to pharmacological interventions: current trends and future directions. Control Clin Trials 2000; 21 Suppl. 5: 218S–25SPubMedCrossRefGoogle Scholar
  9. 9.
    Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114–7PubMedCrossRefGoogle Scholar
  10. 10.
    Bloom BS. Daily regimen and compliance with treatment [editorial]. BMJ 2001; 323: 647PubMedCrossRefGoogle Scholar
  11. 11.
    Morgan SG, Yan L. Persistence with hypertension treatment among community- dwelling BC seniors. Can J Clin Pharmacol 2004; 11: e267–73PubMedGoogle Scholar
  12. 12.
    DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantative review of 50 years of research. Med Care 2004; 42: 200–9PubMedCrossRefGoogle Scholar
  13. 13.
    Pritchard MT, Butow PN, Stevens MM, et al. Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. J Pediatr Hematol Oncol 2006; 28: 816–23PubMedCrossRefGoogle Scholar
  14. 14.
    Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009; 59: 56–66PubMedCrossRefGoogle Scholar
  15. 15.
    Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009; 9: 35–41PubMedCrossRefGoogle Scholar
  16. 16.
    DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794–811PubMedCrossRefGoogle Scholar
  17. 17.
    Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006 Jul 1; 333 (7557): 15. Epub 2006 Jun 21PubMedCrossRefGoogle Scholar
  18. 18.
    Storms W. Clinical trials: are these your patients? J Allergy Clin Immunol 2003; 112 Suppl. 5: S107–11CrossRefGoogle Scholar
  19. 19.
    Miller LG, Hays RD. Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials 2000; 1: 36–46PubMedCrossRefGoogle Scholar
  20. 20.
    Boudes P. Drug compliance in therapeutic trials: a review. Control Clin Trials 1998; 19: 257–68PubMedCrossRefGoogle Scholar
  21. 21.
    Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074–90PubMedCrossRefGoogle Scholar
  22. 22.
    Robiner WN. Enhancing adherence in clinical research. Contemp Clin Trials 2005; 26: 59–77PubMedCrossRefGoogle Scholar
  23. 23.
    International Conference on Harmonization. E8: general considerations for clinical trials [online]. Available from URL: http://www.ich.org/LOB/media/MEDIA484.pdf [Accessed 2009 Sep 20]
  24. 24.
    Urquhart J. Role of patient compliance in clinical pharmacokinetics. Clin Pharmacokinet 1994; 27: 202–15PubMedCrossRefGoogle Scholar
  25. 25.
    Soutter BR, Kennedy MC. Patient compliance assessment in drug trials usage and methods. Aust N Z J Med 1974; 4: 360–4PubMedCrossRefGoogle Scholar
  26. 26.
    Jayaraman S, Rieder MJ, Matsui DM. Compliance assessment in drug trials: has there been improvement in two decades? Can J Clin Pharmacol 2005; 12 (3): e251–3PubMedGoogle Scholar
  27. 27.
    Matsui D. Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am 1997; 44: 1–14PubMedCrossRefGoogle Scholar
  28. 28.
    Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028–35PubMedCrossRefGoogle Scholar
  29. 29.
    Winnick S, Lucas DO, Hartman AL, et al. How do you improve compliance? Pediatrics 2005; 115: e718–24PubMedCrossRefGoogle Scholar
  30. 30.
    Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008; 31: 213–24PubMedCrossRefGoogle Scholar
  31. 31.
    Blowey DL, Hebert D, Arbus G, et al. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 1997; 11: 547–51PubMedCrossRefGoogle Scholar
  32. 32.
    Lau RCW, Matsui D, Greenberg M, et al. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol 1998; 30: 85–90PubMedCrossRefGoogle Scholar
  33. 33.
    McNamara PS, McCormack P, McDonald AJ, et al. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebulizer in children with cystic fibrosis. J Cyst Fibros 2009; 8: 258–63PubMedCrossRefGoogle Scholar
  34. 34.
    Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296–310PubMedCrossRefGoogle Scholar
  35. 35.
    Saini SD, Schoenfeld P, Kaulback K, et al. Effect of medication dosing frequency on adherence in chronic diseases. Am JManag Care 2009; 15: e22–33Google Scholar
  36. 36.
    Richter A, Anton SF, Koch P, et al. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25: 2307–35PubMedCrossRefGoogle Scholar
  37. 37.
    Hayes TL, Hunt JM, Adami A, et al. An electronic pillbox for continuous monitoring of medication adherence. Proceedings of the 28th IEEE EMBS Annual International Conference. IEEE Eng Med Biol Soc 2006 Aug 30–Sep 3; 6400–3Google Scholar
  38. 38.
    Sackett DL, Haynes RB, Guyatt GH, et al., editors. Helping patients follow the treatments you prescribe. In: Clinical epidemiology: a basic science for clinical medicine. Boston (MA): Little, Brown and Company, 1991: 249–81Google Scholar
  39. 39.
    Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Control Clin Trials 2003; 24: 182–99PubMedCrossRefGoogle Scholar
  40. 40.
    Kerr T, Walsh J, Lloyd-Smith E, et al. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep 2005; 2: 200–5PubMedCrossRefGoogle Scholar
  41. 41.
    Simmons MS, Nides MA, Rand CS, et al. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000; 118: 290–5PubMedCrossRefGoogle Scholar
  42. 42.
    Paschal AM, Hawley SR, St. Romain T, et al. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 2008; 49: 1115–22PubMedCrossRefGoogle Scholar
  43. 43.
    Breath monitor tracks medication adherence. AIDS Patient Care STDS 2008; 22 (5): 437–9CrossRefGoogle Scholar
  44. 44.
    Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49: 321–7PubMedCrossRefGoogle Scholar
  45. 45.
    Christensen A, Osterberg LG, Hansen EH. Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens 2009; 27: 1540–51PubMedCrossRefGoogle Scholar
  46. 46.
    Santschi V, Wuerzner G, Schneider M, et al. Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. Eur J Clin Pharmacol 2007; 63: 1179–84PubMedCrossRefGoogle Scholar
  47. 47.
    Shellmer DA, Zelikovsky N. The challenges of using medication event monitoring technology with pediatric transplant patients. Pediatr Transplant 2007; 11: 422–8PubMedCrossRefGoogle Scholar
  48. 48.
    Klocke RA. Ethics of monitoring patient adherence: an evolving dilemma [editorial]. Am J Respir Crit Care Med 1994; 149: 286PubMedGoogle Scholar
  49. 49.
    Shumaker SA, Dugan E, Bowen DJ. Enhancing adherence in randomized controlled clinical trials. Control Clin Trials 2000; 21 Suppl. 5: 226S–32SPubMedCrossRefGoogle Scholar
  50. 50.
    Kastrissios H, Blaschke TF. Medication compliance as a feature in drug development. Annu Rev Pharmacol Toxicol 1997; 37: 451–75PubMedCrossRefGoogle Scholar
  51. 51.
    Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Sys Rev 2006; (1): CD005025Google Scholar
  52. 52.
    Hughes D. When drugs don’t work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics 2007; 25: 621–35PubMedCrossRefGoogle Scholar
  53. 53.
    Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med 2007; 167: 540–50PubMedCrossRefGoogle Scholar
  54. 54.
    Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Sys Rev 2008; (2): CD000011Google Scholar
  55. 55.
    van Dulmen S, Sluijs E, van Dijk L, et al. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion [letter]. BMC Health Serv Res 2008; 8: 47PubMedCrossRefGoogle Scholar
  56. 56.
    Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68 Suppl. 3: S49–59PubMedGoogle Scholar
  57. 57.
    Bangalore S, Kamalakkannan G, Parker S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713–9PubMedCrossRefGoogle Scholar
  58. 58.
    The Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomized trial. Lancet 2009; 373: 1341–51PubMedCrossRefGoogle Scholar
  59. 59.
    Rudd P. Medication packaging: simple solutions to nonadherence problems? Clin Pharmacol Ther 1979; 25: 257–65PubMedGoogle Scholar
  60. 60.
    Huang H, Maguire M, Miller III E, et al. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol 2000; 152: 780–7PubMedCrossRefGoogle Scholar
  61. 61.
    Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ 2004; 82: 935–9PubMedGoogle Scholar
  62. 62.
    Glass BD, Haywood A, Llewelyn V, et al. Compliance aids and medicine stability: new evidence of quality assurance. Curr Drug Saf 2009; 4: 74–8CrossRefGoogle Scholar
  63. 63.
    Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDS 2008; 22: 495–504PubMedCrossRefGoogle Scholar
  64. 64.
    Taddeo D, Egedy M, Frappier J. Adherence to treatment in adolescents. Paediatr Child Health 2008; 13: 19–24PubMedGoogle Scholar
  65. 65.
    Naditz A. Medication compliance — helping patients through technology: modern “smart” pillboxes keep memory-short patients on their medical regimen. Telemed J E Health 2008; 14: 875–80PubMedCrossRefGoogle Scholar
  66. 66.
    Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res 2008; 8: 272PubMedCrossRefGoogle Scholar
  67. 67.
    Sather BC, Forbes JJ, Starck DJ, et al. Effect of a personal automated dose-dispensing system on adherence: a case series. J Am Pharm Assoc 2007; 47: 82–5CrossRefGoogle Scholar
  68. 68.
    Cocosila M, Archer N. A framework for mobile healthcare answers to chronically ill outpatient non-adherence. Inform Prim Care 2005; 13: 145–52PubMedGoogle Scholar
  69. 69.
    Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health 2009; 15: 231–40PubMedCrossRefGoogle Scholar
  70. 70.
    Cocosila M, Archer N, Haynes RB, et al. Can wireless text messaging improve adherence to preventive activities? Results of a randomized controlled trial. Int J Med Inform 2009; 78: 230–8PubMedCrossRefGoogle Scholar
  71. 71.
    Franklin VL, Waller A, Pagliari C, et al. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006; 23: 1332–8PubMedCrossRefGoogle Scholar
  72. 72.
    Miloh T, Annunziato R, Arnon R, et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 2009; 124: e844–50PubMedCrossRefGoogle Scholar
  73. 73.
    Safren SA, Hendriksen ES, Desousa N, et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003; 15: 787–93PubMedCrossRefGoogle Scholar
  74. 74.
    Takacs B, Hanak D. A prototype home robot with an ambient facial interface to improve drug compliance. J Telemed Telecare 2008; 14: 393–5PubMedCrossRefGoogle Scholar
  75. 75.
    Koop A, Mosges R. The use of handheld computers in clinical trials. Control Clin Trials 2002; 23: 469–80CrossRefGoogle Scholar
  76. 76.
    Sahm L, MacCurtain A, Hayden J, et al. Electronic reminders to improve medication adherence: are they acceptable to the patient? Pharm World Sci 2009; 31: 627–9PubMedCrossRefGoogle Scholar
  77. 77.
    Reidel K, Tamblyn R, Patel V, et al. Pilot study of an interactive voice response system to improve medication refill compliance. BMC Med Inform Decis Mak 2008; 8: 46PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  1. 1.Departments of Paediatrics and Medicine, Children’s Hospital, London Health Science CentreUniversity of Western OntarioLondonCanada

Personalised recommendations